Literature DB >> 6159552

Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells.

M Knight, P J Cayley, R H Silverman, D H Wreschner, C S Gilbert, R E Brown, I M Kerr.   

Abstract

The enzyme (2-5A synthetase) which synthesizes ppp(A2'p)nA where n=2 to 4 (collectively referred to as 2-5A) is widely distributed in a variety of cells and tissues in amounts which increase response to interferon and vary with growth and hormone status. 2-5A activates a nuclease which inhibits protein synthesis. The non-phosphorylated 'core' of 2-5A ((A2'p)nA, n=2 to 4) can inhibit DNA synthesis and cell growth. Here we describe convenient and sensitive radioimmune (RI) and radiobinding (RB) assays for core and 2-5A. In combination with more satisfactory high performance liquid chromatography (HPCL) methods using reverse-phase C18 columns, these assays have been used to detect core and 2-5A in crude extracts from interferon-treated cells. The novel 2-5A synthetase products NAD2'p5' A2'p5'A and A5'p45'A2'p5'A2'p5'A (ref. 13), which can also be detected using the RB assay, were not found in significant amounts. The natural occurrence of core has not been described previously.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159552     DOI: 10.1038/288189a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  49 in total

Review 1.  A scientific journey through the 2-5A/RNase L system.

Authors:  Robert H Silverman
Journal:  Cytokine Growth Factor Rev       Date:  2007-07-27       Impact factor: 7.638

2.  Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus.

Authors:  A Muñoz; R A García; A Pérez-Aranda
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

Review 3.  Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.

Authors:  Robert H Silverman
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

4.  A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.

Authors:  Krishnamurthy Malathi; Jayashree M Paranjape; Elena Bulanova; Minsub Shim; Jeanna M Guenther-Johnson; Pieter W Faber; Thomas E Eling; Bryan R G Williams; Robert H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

5.  Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells.

Authors:  A P Rice; R Duncan; J W Hershey; I M Kerr
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.

Authors:  A P Rice; W K Roberts; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  Chemical synthesis and biological characterization of phosphorothioate analogs of 2', 5'-3'-deoxyadenylate trimer.

Authors:  R W Sobol; R Charubala; W Pfleiderer; R J Suhadolnik
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

8.  (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.

Authors:  A Schattner; G Merlin; V Bregman; T Hahn; S Levin; M Revel; D Wallach
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Maintenance of protein synthesis in spite of mRNA breakdown in interferon-treated HeLa cells infected with reovirus.

Authors:  T W Nilsen; P A Maroney; C Baglioni
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

10.  Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.

Authors:  D H Wreschner; T C James; R H Silverman; I M Kerr
Journal:  Nucleic Acids Res       Date:  1981-04-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.